Early statin use after MI may increase second-event risk for some
Previous observational studies found that starting statins early after an MI reduces the risk of second heart attacks and death. But a new, larger observational study published last month in JAMA found no such reduction with early initiation (< 7 days)-and even an increased risk of MI or death for patients whose cholesterol levels were below treatment guideline levels.
Jenny Goins, interim head of the National Alliance of Healthcare Purchaser Coalitions, says employers need the same visibility into medical benefits that a new Department of Labor rule gives them into PBM compensation.
People with ADHD had a 70% higher risk of death from any cause in a 19-study meta-analysis, with excess deaths from suicide, injury and natural causes.
Bronchiectasis affected 221.6 per 100,000 people in the U.S. over five years, which is higher than earlier national estimates, according to a study published in CHEST.
Adding Sunharbo (asundexian), a first-in-class factor XI inhibitor, to single or dual antiplatelet therapy reduces ischemic stroke risk without increasing the risk of major bleeding.